Main Innovation Point
This is the only protein induced in vivo tissue reprogramming technology that is currently available and safe for human clinical applications. This technology performs tissue reprogramming in situ inside diseased tissues to generate transient reprogrammed cells, since tissue environment is a differentiating environment.
Transient reprogrammed cellsin-situ differentiate into normal tissue cells induced by tissue environment, this canrepair damaged tissue or regenerate disease tissue.
The technology is highly efficient in animal studies for the treatment of different diseases, including cancers, heart disease and ophthalmic diseases.
This technology requires no cell transplantation, providing a revolutionary technology platform for protein induced regenerative medicine.
440 Burroughs Street, Ste 448;Detroit, MI 48202, USA
001 618 201 4310
Asia Pacific Headquarters:
Fuent Biotechnology Co. Ltd (Shanghai)
12A, Junyao International Plaza, No. 789, Zhaojiabang Road, Shanghai